{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:14:58Z","timestamp":1784128498802,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04177-z","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T16:57:07Z","timestamp":1738601827000},"page":"511-522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of prognostic factors and establishment of a recurrence risk prediction model for papillary thyroid carcinoma based on BRAF stratification"],"prefix":"10.1007","volume":"88","author":[{"given":"Ang","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahe","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"issue":"4","key":"4177_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","volume":"9","author":"A Miranda-Filho","year":"2021","unstructured":"A Miranda-Filho, J Lortet-Tieulent, F Bray, B Cao, S Franceschi, S Vaccarella, et al., Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 9(4), 225\u2013234 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"4177_CR2","doi-asserted-by":"publisher","first-page":"e220293","DOI":"10.1530\/ERC-22-0293","volume":"30","author":"C Christofer Juhlin","year":"2023","unstructured":"C Christofer Juhlin, O Mete, Z.W Baloch, The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading. Endocr. Relat. Cancer 30(2), e220293 (2023).","journal-title":"Endocr. Relat. Cancer"},{"issue":"8","key":"4177_CR3","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00268-002-6612-1","volume":"26","author":"ID Hay","year":"2002","unstructured":"I.D Hay, G.B Thompson, C.S Grant, E.J Bergstralh, C.E Dvorak, C.A Gorman, et al., Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940\u20131999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J. Surg. 26(8), 879\u2013885 (2002).","journal-title":"World J. Surg."},{"key":"4177_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R Haugen, E.K Alexander, K.C Bible, G.M Doherty, S.J Mandel, Y.E Nikiforov, et al., 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1\u2013133 (2016).","journal-title":"Thyroid"},{"issue":"12","key":"4177_CR5","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.6004\/jnccn.2018.0089","volume":"16","author":"RI Haddad","year":"2018","unstructured":"R.I Haddad, C Nasr, L Bischoff, N.L Busaidy, D Byrd, G Callender, et al., NCCN guidelines insights: thyroid carcinoma, version 2.2018. J. Natl Compr. Canc Netw. 16(12), 1429\u20131440 (2018).","journal-title":"J. Natl Compr. Canc Netw."},{"issue":"11","key":"4177_CR6","doi-asserted-by":"publisher","first-page":"E1852","DOI":"10.1210\/jc.2013-2292","volume":"98","author":"MN Nikiforova","year":"2013","unstructured":"M.N Nikiforova, A.I Wald, S Roy, M.B Durso, Y.E Nikiforov, Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. J. Clin. Endocrinol. Metab. 98(11), E1852\u2013E1860 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"16","key":"4177_CR7","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.3390\/ijms21165629","volume":"21","author":"YY Cho","year":"2020","unstructured":"Y.Y Cho, S.Y Park, J.H Shin, Y.L Oh, J.H Choe, J.H Kim, et al., Highly sensitive and specific molecular test for mutations in the diagnosis of thyroid nodules: a prospective study of BRAF-prevalent population. Int. J. Mol. Sci. 21(16), 5629 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"4177_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1089\/thy.2017.0422","volume":"28","author":"L Jianyong","year":"2018","unstructured":"L Jianyong, Z Jinjing, L Zhihui, W Tao, G Rixiang, Z Jingqiang, A nomogram based on the characteristics of metastatic lymph nodes to predict papillary thyroid carcinoma recurrence. Thyroid 28(3), 301\u2013310 (2018).","journal-title":"Thyroid"},{"key":"4177_CR9","doi-asserted-by":"publisher","first-page":"104732","DOI":"10.1016\/j.oraloncology.2020.104732","volume":"106","author":"A Subash","year":"2020","unstructured":"A Subash, P Sinha, A Singh, BRAF mutation and age in differentiated thyroid cancer risk stratification: two sides of the same coin. Oral. Oncol. 106, 104732 (2020).","journal-title":"Oral. Oncol."},{"issue":"2","key":"4177_CR10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/thy.2015.0391","volume":"26","author":"Y Chen","year":"2016","unstructured":"Y Chen, P.M Sadow, H Suh, K.E Lee, J.Y Choi, Y.J Suh, et al., BRAF(V600E) is correlated with recurrence of papillary thyroid microcarcinoma: a systematic review, multi-institutional primary data analysis, and meta-analysis. Thyroid 26(2), 248\u2013255 (2016).","journal-title":"Thyroid"},{"issue":"1","key":"4177_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1200\/JCO.2014.56.8253","volume":"33","author":"M Xing","year":"2015","unstructured":"M Xing, A.S Alzahrani, K.A Carson, Y.K Shong, T.Y Kim, D Viola, et al., Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. J. Clin. Oncol. 33(1), 42\u201350 (2015).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"4177_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1200\/JCO.2014.59.3657","volume":"33","author":"M Yarchoan","year":"2015","unstructured":"M Yarchoan, V.A LiVolsi, M.S Brose, BRAF mutation and thyroid cancer recurrence. J. Clin. Oncol. 33(1), 7\u20138 (2015).","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"4177_CR13","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1200\/JCO.2014.60.0999","volume":"33","author":"C Bal","year":"2015","unstructured":"C Bal, S Ballal, Is there any true association between BRAF V600E mutation and recurrence, particularly in low-risk, papillary thyroid cancer? J. Clin. Oncol. 33(22), 2481 (2015).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"4177_CR14","doi-asserted-by":"publisher","first-page":"300060522114988","DOI":"10.1177\/03000605221149880","volume":"51","author":"C Geng","year":"2023","unstructured":"C Geng, S Tian, X Gao, X Li, Q Ru, P Zhang, Establishment and validation of a nomogram to predict structural incomplete response in papillary thyroid carcinoma patients: a retrospective study. J. Int. Med. Res. 51(1), 3000605221149880 (2023).","journal-title":"J. Int. Med. Res."},{"issue":"6","key":"4177_CR15","doi-asserted-by":"publisher","first-page":"e230195","DOI":"10.1530\/ETJ-23-0195","volume":"12","author":"HR Won","year":"2023","unstructured":"H.R Won, M.G Kim, M.S Kim, J.W Chang, B.S Koo, Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence. Eur. Thyroid. J. 12(6), e230195 (2023).","journal-title":"Eur. Thyroid. J."},{"issue":"3","key":"4177_CR16","doi-asserted-by":"publisher","first-page":"L7","DOI":"10.1530\/ERC-17-0453","volume":"25","author":"L Lamartina","year":"2018","unstructured":"L Lamartina, G Grani, E Arvat, A Nervo, M.C Zatelli, R Rossi, et al., 8th edition of the AJCC\/TNM staging system of thyroid cancer: what to expect (ITCO#2). Endocr. Relat. Cancer 25(3), L7\u2013L11 (2018).","journal-title":"Endocr. Relat. Cancer"},{"issue":"7","key":"4177_CR17","doi-asserted-by":"publisher","first-page":"7868","DOI":"10.1002\/cam4.5555","volume":"12","author":"P Guo","year":"2023","unstructured":"P Guo, X Wang, L Xia, N Shawureding, Z Hu, Analysis of factors associated with the prognosis of papillary thyroid cancer and the construction of a survival model. Cancer Med. 12(7), 7868\u20137876 (2023).","journal-title":"Cancer Med."},{"issue":"1","key":"4177_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.surg.2020.04.003","volume":"169","author":"MD Bortz","year":"2021","unstructured":"M.D Bortz, K Kuchta, D.J Winchester, R.A Prinz, T.A Moo-Young, Extrathyroidal extension predicts negative clinical outcomes in papillary thyroid cancer. Surgery 169(1), 2\u20136 (2021).","journal-title":"Surgery"},{"key":"4177_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.oraloncology.2019.05.023","volume":"94","author":"WR Choi","year":"2019","unstructured":"W.R. Choi, J.L. Roh, G. Gong, K.J. Cho, S.H. Choi, S.Y. Nam et al. Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence. Oral. Oncol. 94, 106\u2013110 (2019)","journal-title":"Oral. Oncol."},{"key":"4177_CR20","doi-asserted-by":"publisher","first-page":"759049","DOI":"10.3389\/fendo.2021.759049","volume":"12","author":"TH Zhou","year":"2021","unstructured":"T.H. Zhou, B. Lin, F. Wu, K.N. Lu, L.L. Mao, L.Q. Zhao et al. Extranodal extension is an independent prognostic factor in papillary thyroid cancer: a propensity score matching analysis. Front. Endocrinol. 12, 759049 (2021)","journal-title":"Front. Endocrinol."},{"issue":"3","key":"4177_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/SLA.0000000000001420","volume":"262","author":"L Yip","year":"2015","unstructured":"L Yip, M.N Nikiforova, J.Y Yoo, K.L McCoy, M.T Stang, M.J Armstrong, et al., Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients. Ann. Surg. 262(3), 519\u2013525 (2015).","journal-title":"Ann. Surg."},{"issue":"6","key":"4177_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00595-004-2739-z","volume":"34","author":"KW Chung","year":"2004","unstructured":"K.W Chung, M.C Chang, D.Y Noh, S.K Oh, K.J Choe, Y.K Youn, RET oncogene expression of papillary thyroid carcinoma in Korea. Surg. Today 34(6), 485\u2013492 (2004).","journal-title":"Surg. Today"},{"issue":"4","key":"4177_CR23","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3390\/biom10040625","volume":"10","author":"D Pamedytyte","year":"2020","unstructured":"D Pamedytyte, V Simanaviciene, D Dauksiene, E Leipute, A Zvirbliene, V Sarauskas, et al., Association of MicroRNA expression and BRAF(V600E) mutation with recurrence of thyroid cancer. Biomolecules 10(4), 625 (2020).","journal-title":"Biomolecules"},{"issue":"4","key":"4177_CR24","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1210\/clinem\/dgad667","volume":"109","author":"P Li","year":"2024","unstructured":"P Li, Y Liu, T Wei, X Wang, J Zhu, R Yang, et al., Effect and interactions of BRAF on lymph node metastasis in papillary thyroid carcinoma with hashimoto thyroiditis. J. Clin. Endocrinol. Metab. 109(4), 944\u2013954 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4177_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12893-024-02309-2","volume":"24","author":"H Cai","year":"2024","unstructured":"H Cai, L Zhuge, Z Huang, S Wang, P Shi, D Yan, et al., Distinct risk factors of lateral lymph node metastasis in patients with papillary thyroid cancer based on age stratification. BMC Surg. 24(1), 24 (2024).","journal-title":"BMC Surg."},{"issue":"5","key":"4177_CR26","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00405-022-07812-x","volume":"280","author":"WX Wu","year":"2023","unstructured":"W.X Wu, G.F Qi, J.W Feng, J Ye, L.Z Hong, F Wang, et al., Construction of prediction models for determining the risk of lateral lymph node metastasis in patients with thyroid papillary carcinoma based on gender stratification. Eur. Arch. Otorhinolaryngol. 280(5), 2511\u20132523 (2023).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"12","key":"4177_CR27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/cncy.21614","volume":"123","author":"MP Pusztaszeri","year":"2015","unstructured":"M.P Pusztaszeri, J.F Krane, W.C Faquin, BRAF testing and thyroid FNA. Cancer Cytopathol. 123(12), 689\u2013695 (2015).","journal-title":"Cancer Cytopathol."},{"issue":"8","key":"4177_CR28","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1136\/jclinpath-2014-202348","volume":"67","author":"DN Poller","year":"2014","unstructured":"D.N Poller, S Glaysher, A Agrawal, S Caldera, D Kim, C Yiangou, BRAF V600 co-testing in thyroid FNA cytology: short-term experience in a large cancer centre in the UK. J. Clin. Pathol. 67(8), 684\u2013689 (2014).","journal-title":"J. Clin. Pathol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04177-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04177-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04177-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T07:47:22Z","timestamp":1747036042000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04177-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["4177"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04177-z","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Medical Ethics Committee of the Sun Yat-Sen University Cancer Center. Written informed consents were exempted because of retrospective analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval"}},{"value":"All authors declare the submission to this journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}